About Curavac Europe
Curavac Europe is a public limited company (NV/SA) based in Rixensart, founded in 2003. Its main activity is classified as "Vervaardiging van farmaceutische grondstoffen". For the 2024 financial year, Curavac Europe reported a loss of €257,915. That makes 5 loss-making financial years in a row for Curavac Europe. Revenue was not published, which is common for abbreviated accounts. The gross margin came to -€150,346. Equity stands at €1.1 million, a solvency ratio of 45%. In 2007 it was €16,158. 18 annual accounts are available, covering 2007 to 2024.
- Sectors
- Forestry companies
- Signals
-
Reporting lossesReporting losses € -233K
The company reported a loss in the latest financial year.
Poor liquidityPoor liquidity 0.53The current ratio is below 1: may be insufficient to cover short-term debt.
Negative cashflowNegative cashflow € -258KOperating cash flow was negative in the latest financial year.
Negative EBITDANegative EBITDA € -233KEBITDA is negative: operating activities are loss-making.
Strong equityStrong equity € 1.13MStrong equity provides a buffer against setbacks.
Low riskLow risk 44.9%Good solvency (> 30%) points to long-term financial stability.
Healthy social debtHealthy social debt 10.0%Social debts stay manageable relative to personnel costs.
Financial ratios
|
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
2024
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
2023
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
2022
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
2021
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
|---|---|---|---|---|
|
€
-150K
|
€
43K
|
€
66K
|
€
-35K
|
|
|
€
-233K
|
€
27K
|
€
-62K
|
€
-62K
|
|
|
€
-258K
|
€
-16K
|
€
-93K
|
€
-79K
|
|
|
€
1.13M
|
€
391K
|
€
407K
|
€
404K
|
|
|
44.86%
|
17.69%
|
19.1%
|
18.58%
|
|
|
€
1.39M
|
€
1.82M
|
€
1.73M
|
€
1.77M
|
|
|
€
201K
|
€
13
|
|
€
40K
|
Publications 20
All publications- Statuts (Traduction, Coordination, Autres Modifications, ) - Demissions, Nominations 19/08/2024
- Demissions, Nominations 12/05/2023
- Statuts (Traduction, Coordination, Autres Modifications, ) - Demissions, Nominations - Assemblee Generale - Annee Comptable 11/10/2022
- Demissions, Nominations 15/05/2019
- Me. - Comptes Annuels 30.09.2016, App 07.02.2017, Dpt 20.02.2017 17047-0341-013 23/02/2017
Frequently asked questions
Answers to the most common questions about Curavac Europe, based on official government data and the filed annual accounts.
What is the VAT number of Curavac Europe?
The VAT number of Curavac Europe is BE0479.403.989.
When was Curavac Europe established?
Curavac Europe was founded in 28-01-2003.
What is the official address of Curavac Europe?
The official address of Curavac Europe is Avenue De Villefranche 80 Rixensart 1330.
What is the legal form of Curavac Europe?
The juridical form of Curavac Europe is Public limited company (NV/SA).
What is the annual revenue of Curavac Europe?
The 2024 accounts of Curavac Europe do not report revenue. Smaller companies that file abbreviated accounts are not required to publish it.
Is Curavac Europe a reliable company?
Curavac Europe is a registered Rechtspersoon with company number 0479.403.989 and can be verified through the official CBE database.
What is the credit limit of Curavac Europe?
The estimated credit limit of Curavac Europe is €47,112.
Is Curavac Europe still active?
Curavac Europe currently has the status "Normal situation" and is active.